[Myasthenia gravis associated with HIV infection].
Murai
H
H
Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University.
Kira
J
J
D001323:Autoantibodies / Q000032:analysis; D015415:Biomarkers / Q000032:analysis; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005914:Globins / Q000627:therapeutic use; D015658:HIV Infections; D006801:Humans; D009157:Myasthenia Gravis / Q000175:diagnosis / Q000628:therapy / Q000821:virology*; D011239:Prednisolone / Q000627:therapeutic use; D011379:Prognosis; D011729:Pyridostigmine Bromide / Q000627:therapeutic use; D011950:Receptors, Cholinergic / Q000276:immunology
D001323:Autoantibodies; D015415:Biomarkers; D002800:Cholinesterase Inhibitors; D011950:Receptors, Cholinergic; D005914:Globins; D011239:Prednisolone; D011729:Pyridostigmine Bromide